Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
5.94
+0.20 (3.48%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $471.81 million as of October 26, 2026. It is the 14,910th most valuable company in the world and the 2,777th biggest in the United States. Its market cap has decreased by 50.85% in one year.
Market Cap
471.81M
Enterprise Value
841.36M
1-Year Change
-50.85%
Global Rank
Country Rank
#2,777 United States
Category
ChartMarket Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has decreased from $527.13M to $471.81M, a decrease of -10.49%. That is a compound annual growth rate of -1.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 471.81M | -60.02% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arvinas | 477.32M |
| Monopar Therapeutics | 474.21M |
| Neurogene | 471.27M |
| DiaMedica Therapeutics | 470.23M |
| BlossomHill Therapeutics | 465.01M |
| Eupraxia Pharmaceuticals | 450.95M |
| Surrozen | 445.78M |
| AgomAb Therapeutics NV | 445.69M |